AP NEWS

Innovations in Biopharmaceutical Treatments, 2018 Report - ResearchAndMarkets.com

July 24, 2018

DUBLIN--(BUSINESS WIRE)--Jul 24, 2018--The “Innovations in Biopharmaceutical Treatments” report has been added to ResearchAndMarkets.com’s offering.

This Drug Discovery TOE depicts trends across biopharmaceuticals for psoriasis, hepatocellular carcinoma, Crohn’s disease, migraine, HIV, and hepatitis B infection, among others. Clinical trial analysis of Etanercept biosimilar is also presented.

The Drug Discovery TechVision Opportunity Engine (TOE) reports and analyzes about the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into crucial developments in this industry domain.

Technologies profiled include those used for biomarker and target discovery such as high throughput screening, signal transduction, micro array, RNAi, metabolomics, toxicogenomics, biosensors and nanotechnology. In addition to these, a fair focus shall be dedicated to the latest trends in therapeutic approaches across a diversity of diseases including infectious, genetic, metabolic, neurological, cardiac, and autoimmune disorders.

Key Topics Covered:

1. Advancements in Drug Discovery and Development

FDA-approved Drug to Provide Affordable Psoriasis Treatment Option

Ramucirumab Proves Promising Against Hepatocellular Carcinoma and Bladder Cancer

Monoclonal Antibody Targeting Specific Cell Marker in Crohn’s Disease

Calcitonin Gene-Related Peptide (CGRP) as a Drug Target for Migraine Prevention

Breakthrough Therapy for Multi-drug Resistant HIV Infection

Enhancing Biologics Manufacturing Capabilities

Accelerating Biosimilar Commercialization

Groundbreaking Treatment for X-linked Hypophosphatemia

Novel Immunotherapies for Hepatitis B and HIV

2. Drug Development Analysis and Key Contacts

Clinical Trial Analysis of Etanercept Biosimilar

Industry Contacts

For more information about this report visit https://www.researchandmarkets.com/research/ht9mqp/innovations_in?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180724005866/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Biopharmaceuticals

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 07/24/2018 02:19 PM/DISC: 07/24/2018 02:19 PM

http://www.businesswire.com/news/home/20180724005866/en

AP RADIO
Update hourly